Drugs Made In America Acquisition II Corp. (DMII)
NASDAQ: DMII · Real-Time Price · USD
9.97
+0.01 (0.10%)
At close: Sep 29, 2025, 4:00 PM EDT
9.98
+0.01 (0.10%)
After-hours: Sep 29, 2025, 4:00 PM EDT

Company Description

Drugs Made In America Acquisition II Corp. engages in effecting a merger, share exchange, asset acquisition, share purchase, recapitalization, reorganization, or other similar business combination with one or more businesses.

Drugs Made In America Acquisition II Corp. was incorporated in 2024 and is based in Fort Lauderdale, Florida.

Drugs Made In America Acquisition II Corp.
CountryUnited States
Founded2024
IPO DateSep 25, 2025
IndustryShell Companies
SectorFinancials
CEOLynn Stockwell

Contact Details

Address:
1 East Broward Boulevard, Suite 700
Fort Lauderdale, Florida 33301
United States
Phone954 870 3099

Stock Details

Ticker SymbolDMII
ExchangeNASDAQ
Fiscal YearJanuary - December
Reporting CurrencyUSD
IPO Price$10.00
CIK Code0002040475
SIC Code6770

Key Executives

NamePosition
Lynn StockwellChief Executive Officer and Executive Chair of the Board
Glenn WormanChief Financial Officer
Catherine DoDirector Nominee
G. Sridhar PrasadDirector Nominee
Myron W. ShulganDirector Nominee

Latest SEC Filings

DateTypeTitle
Sep 25, 2025424B4Prospectus
Sep 24, 2025EFFECTNotice of Effectiveness
Sep 24, 2025CERTCertification by an exchange approving securities for listing
Sep 24, 20258-A12BRegistration of securities
Sep 16, 2025S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Sep 15, 2025S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Sep 5, 2025S-1/A[Amend] General form for registration of securities under the Securities Act of 1933
Jul 21, 2025S-1General form for registration of securities under the Securities Act of 1933
Apr 25, 2025DRS/A[Amend] [Cover] Draft Registration Statement
Mar 19, 2025DRS[Cover] Draft Registration Statement